Engineering access: How Medicines for All is making lifesaving drugs affordable
From a Richmond lab bench to global impact, VCU’s Medicines for All Institute is reengineering lifesaving drugs to be more affordable and accessible, transforming the future for millions worldwide.
Pharmaceutical leaders AstraZeneca, Eli Lilly and Merck partner with VCU College of Engineering and other Virginia universities to form the Virginia Center for Advanced Pharmaceutical Manufacturing
The $12.5 billion capital investment seeks to produce 2,000-2,500 highly-trained professionals.
VCU Innovators of the Year advance lifesaving aerosol therapy for newborns
The collaborative work of Michael Hindle in the School of Pharmacy and P. Worth Longest in the College of Engineering has global implications.
Pharmaceutical engineering programs at the VCU College of Engineering attract manufacturers like Eli Lilly to invest in Virginia
The Virginia Commonwealth University (VCU) College of Engineering’s pioneering doctoral program in pharmaceutical engineering played a pivotal role in attracting Eli Lilly’s $5 billion manufacturing facility to Goochland County.
VCU School of Medicine M.D. Ph.D. student receives F30 grant from National Institute of Diabetes and Kidney Diseases
Galen Goldscheitter, an M.D. Ph.D. student from the Virginia Commonwealth University School of Medicine, has been awarded a fellowship position by the National Institute of Diabetes and Digestive and Kidney Diseases.
DARPA awards VCU $4.875 million for development of modular drug manufacturing platform
College of Engineering professor James Ferri, Ph.D. applies continuous manufacturing technology to address critical drug shortages
VCU inventors take a big step toward lifesaving therapy for premature infants in respiratory distress
The simple-to-use powder inhaler from Michael Hindle and Worth Longest shows strong test results and moves closer to market.
VCU Engineering professor awarded $100,000 grant to advance nasal drug delivery technology
Laleh Golshahi, Ph.D., associate and Engineering Foundation professor in the Department of Mechanical and Nuclear Engineering at Virginia Commonwealth University, has received a $100,000 grant from the Virginia Innovation Partnership Corporation (VIPC) to advance her team’s development of anatomically realistic nasal casts for pharmaceutical testing.
College of Engineering researchers develop technology to increase production of biologic pharmaceuticals for diabetes treatment
Chemical and Life Science Engineering Professor Michael “Pete” Peters, Ph.D., is investigating more efficient ways to manufacture biologic pharmaceuticals using a radial flow bioreactor he developed.
Class of 2024: Nadia Tasnim Ahmed is the nation’s first to earn this degree
She and VCU are trailblazers through the Ph.D. program in pharmaceutical engineering.
